Effectiveness of the Roy adaptation model-based nursing intervention in improving physiological, psychological, and social outcomes in patients with Parkinson's disease.

OBJECTIVE

This study aimed to evaluate the effectiveness of a comprehensive nursing intervention based on Roy's Adaptation Model (RAM) in improving quality of life, psychological adaptation, and social functioning in patients with Parkinson's disease (PD).

METHODS

A total of 96 patients with idiopathic PD were randomly assigned to the RAM group or the usual care group. The RAM intervention included a 3-month program addressing physiological, psychological, role function, and interdependence adaptation needs. Outcomes were assessed at baseline, 1 month, 3 months, and 6 months using the Scale for Outcomes in Parkinson' s Disease - Autonomic Symptoms (SCOPA-AUT), Pittsburgh Sleep Quality Index (PSQI), Fatigue Severity Scale (FSS), Beck Depression Inventory-II (BDI-II), Beck Anxiety Inventory (BAI), General Self-Efficacy Scale (GSES), Parkinson' s Disease Social Functioning Scale (PDSFS), Multidimensional Scale of Perceived Social Support (MSPSS), and Parkinson' s Disease Questionnaire-39 (PDQ-39).

RESULTS

The RAM group demonstrated significant improvements in autonomic function, sleep quality, and fatigue compared to the usual care group (SCOPA-AUT, PSQI, and FSS). Psychological adaptation improved with reduced depressive and anxiety symptoms (BDI-II and BAI) and increased self-efficacy (GSES). Role function and interdependence adaptation were significantly enhanced, as indicated by higher PDSFS and MSPSS scores. Quality of life, assessed using PDQ-39, showed significant and sustained improvements across all domains, including mobility, activities of daily living, emotional well-being, and social support.

CONCLUSION

The RAM-based care intervention effectively enhanced physiological and psychological outcomes, social functioning, and quality of life in PD patients, highlighting its value in promoting holistic, patient-centered nursing care.

CLINICAL TRIAL NUMBER: Not applicable.